Nimesulide: an NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.1, Iss.2, 2000-01, pp. : 277-286

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Understanding the COX-2/NSAID Dilemma

By Roth Sanford H.

Drugs, Vol. 65, Iss. 14, 2005-01 ,pp. : 1915-1917

Adis International

Access to resources Recommend Favorite

COX Inhibition and NSAID-Induced Gastric Damage - Roles in Various Pathogenic Events

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 5, 2005-01 ,pp. : 475-486

Bentham Science Publishers

Access to resources Recommend Favorite

COX-1, COX-2 and the topical effect in NSAID-induced enteropathy

By Hotz-Behofsits C. M. Walley M. J. M. Simpson R. Bjarnason I. T.

Inflammopharmacology, Vol. 11, Iss. 4-6, 2003-12 ,pp. : 363-370

VSP

Access to resources Recommend Favorite

Comparison of the Effects of Nimesulide and Nimesulide-L-lysine on PGE₂ Production by COX-1 and COX-2 and on Chondrocyte Metabolism In-vitro

By de Leval X. Henrotin Y. Labasse A. Neven P. Delarge J. Somers F. Masereel B. Pirotte B.

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 2, 2000-02 ,pp. : 83-87

Pharmaceutical Press

Access to resources Recommend Favorite

NSAID-related CV risks not defined by COX-2 selectivity alone

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite